Other Species / Isoforms
  PEA-15 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y4
____MAEYGtLLQDL
0 1
PEA-15 (human) ____MAEyGtLLQDL Y4-p
PEA-15 iso2 (human) TSPVMAEYGTLLQDL Y25
PEA-15 (mouse) ____MAEYGtLLQDL Y4
PEA-15 (rat) ____MAEYGTLLQDL Y4
PEA-15 (hamster) ____MAEYGTLLQDL Y4
PEA-15 (cow) ____MAEYGTLLQDL Y4
T6-p
__MAEYGtLLQDLTN
0 2
PEA-15 (human) __MAEyGtLLQDLTN T6-p
PEA-15 iso2 (human) PVMAEYGTLLQDLTN T27
PEA-15 (mouse) __MAEYGtLLQDLTN T6-p
PEA-15 (rat) __MAEYGTLLQDLTN T6
PEA-15 (hamster) __MAEYGTLLQDLTN T6
PEA-15 (cow) __MAEYGTLLQDLTN T6
K24
LEDLEQLKsACKEDI
0 1
PEA-15 (human) LEDLEQLksACkEDI K24-ub
PEA-15 iso2 (human) LEDLEQLKSACKEDI K45
PEA-15 (mouse) LEDLEQLKsACKEDI K24
PEA-15 (rat) LEDLEQLKSACKEDI K24
PEA-15 (hamster) LEDLEQLKSACKEDI K24
PEA-15 (cow) LEDLEQLKSACKEDI K24
S25-p
EDLEQLKsACKEDIP
Upstream
0 3
Treatment
  • insulin
PEA-15 (human) EDLEQLksACkEDIP S25-p
PEA-15 iso2 (human) EDLEQLKSACKEDIP S46
PEA-15 (mouse) EDLEQLKsACKEDIP S25-p
PEA-15 (rat) EDLEQLKSACKEDIP S25
PEA-15 (hamster) EDLEQLKSACKEDIP S25
PEA-15 (cow) EDLEQLKSACKEDIP S25
K28
EQLKsACKEDIPSEK
0 1
PEA-15 (human) EQLksACkEDIPSEK K28-ub
PEA-15 iso2 (human) EQLKSACKEDIPSEK K49
PEA-15 (mouse) EQLKsACKEDIPSEK K28
PEA-15 (rat) EQLKSACKEDIPSEK K28
PEA-15 (hamster) EQLKSACKEDIPSEK K28
PEA-15 (cow) EQLKSACKEDIPSEK K28
S43
SEEITTGSAWFSFLE
0 2
PEA-15 (human) SEEITTGsAWFSFLE S43-p
PEA-15 iso2 (human) SEEITTGSAWFSFLE S64
PEA-15 (mouse) SEEITTGSAWFSFLE S43
PEA-15 (rat) SEEITTGSAWFSFLE S43
PEA-15 (hamster) SEEITTGSAWFSFLE S43
PEA-15 (cow) SEEITTGSAWFSFLE S43
K54-ub
SFLESHNkLDKDNLs
0 2
PEA-15 (human) SFLESHNkLDKDNLs K54-ub
PEA-15 iso2 (human) SFLESHNKLDKDNLS K75
PEA-15 (mouse) SFLESHNkLDKDNLs K54-ub
PEA-15 (rat) SFLESHNKLDKDNLs K54
PEA-15 (hamster) SFLESHNKLDKDNLS K54
PEA-15 (cow) SFLESHNKLDKDNLS K54
S61-p
kLDKDNLsYIEHIFE
Upstream
0 10
Treatment
  • insulin
PEA-15 (human) kLDKDNLsYIEHIFE S61-p
PEA-15 iso2 (human) KLDKDNLSYIEHIFE S82
PEA-15 (mouse) kLDKDNLsYIEHIFE S61-p
PEA-15 (rat) KLDKDNLsYIEHIFE S61-p
PEA-15 (hamster) KLDKDNLSYIEHIFE S61
PEA-15 (cow) KLDKDNLSYIEHIFE S61
S90-p
RTRVLKIsEEEELDT
Upstream
0 9
Treatment
  • ischemia
PEA-15 (human) RTRVLKIsEEDELDt S90-p
PEA-15 iso2 (human) RTRVLKISEEDELDT S111
PEA-15 (mouse) RTRVLKIsEEEELDT S90-p
PEA-15 (rat) RTRVLKIsEEDELDT S90-p
PEA-15 (hamster) RTRVLKISEEDELDT S90
PEA-15 (cow) RTRVLKISEEDELDT S90
T97
sEEEELDTkLtRIPs
0 2
PEA-15 (human) sEEDELDtkLtRIPs T97-p
PEA-15 iso2 (human) SEEDELDTKLTRIPS T118
PEA-15 (mouse) sEEEELDTkLtRIPs T97
PEA-15 (rat) sEEDELDTkLTRIPs T97
PEA-15 (hamster) SEEDELDTKLTRIPs T97
PEA-15 (cow) SEEDELDTKLTRIPs T97
K98
EEEELDTKLtRIPsA
0 1
PEA-15 (human) EEDELDtKLtRIPsA K98
PEA-15 iso2 (human) EEDELDTKLTRIPSA K119
PEA-15 (mouse) EEEELDTKLtRIPsA K98
PEA-15 (rat) EEDELDTkLTRIPsA K98-ac
PEA-15 (hamster) EEDELDTKLTRIPsA K98
PEA-15 (cow) EEDELDTKLTRIPsA K98
K98-ub
EEEELDTkLtRIPsA
0 5
PEA-15 (human) EEDELDtkLtRIPsA K98-ub
PEA-15 iso2 (human) EEDELDTKLTRIPSA K119
PEA-15 (mouse) EEEELDTkLtRIPsA K98-ub
PEA-15 (rat) EEDELDTKLTRIPsA K98
PEA-15 (hamster) EEDELDTKLTRIPsA K98
PEA-15 (cow) EEDELDTKLTRIPsA K98
T100-p
EELDTkLtRIPsAKK
0 22
PEA-15 (human) DELDtkLtRIPsAKK T100-p
PEA-15 iso2 (human) DELDTKLTRIPSAKK T121
PEA-15 (mouse) EELDTkLtRIPsAKK T100-p
PEA-15 (rat) DELDTkLTRIPsAKK T100
PEA-15 (hamster) DELDTKLTRIPsAKK T100
PEA-15 (cow) DELDTKLTRIPsAKK T100
S104-p
TkLtRIPsAKKyKDI
Upstream
Downstream
10 347
PEA-15 (human)
S104-p
PEA-15 (mouse)
S104-p
PEA-15 (rat)
S104-p
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • PKCA (mouse)
Putative in vivo kinases:
  • PKCA (mouse)
Treatment
  • A23187
  • EGTA
  • endothelin
  • insulin
  • ionomycin
  • LPS
  • LY294002
  • okadaic_acid
  • phorbol_ester
  • staurosporine
PEA-15 (human) tkLtRIPsAKKykDI S104-p
PEA-15 iso2 (human) TKLTRIPSAKKYKDI S125
PEA-15 (mouse) TkLtRIPsAKKyKDI S104-p
PEA-15 (rat) TkLTRIPsAKKYKDI S104-p
PEA-15 (hamster) TKLTRIPsAKKYKDI S104-p
PEA-15 (cow) TKLTRIPsAKKYKDI S104-p
Y108-p
RIPsAKKyKDIIRQP
0 9
PEA-15 (human) RIPsAKKykDIIRQP Y108-p
PEA-15 iso2 (human) RIPSAKKYKDIIRQP Y129
PEA-15 (mouse) RIPsAKKyKDIIRQP Y108-p
PEA-15 (rat) RIPsAKKYKDIIRQP Y108
PEA-15 (hamster) RIPsAKKYKDIIRQP Y108
PEA-15 (cow) RIPsAKKYKDIIRQP Y108
K109
IPsAKKyKDIIRQPs
0 1
PEA-15 (human) IPsAKKykDIIRQPs K109-m1
PEA-15 iso2 (human) IPSAKKYKDIIRQPS K130
PEA-15 (mouse) IPsAKKyKDIIRQPs K109
PEA-15 (rat) IPsAKKYKDIIRQPs K109
PEA-15 (hamster) IPsAKKYKDIIRQPs K109
PEA-15 (cow) IPsAKKYKDIIRQPs K109
S116-p
KDIIRQPsEEEIIKL
Upstream
Downstream
11 1178
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • CAMK2A (mouse)
  • CK2A1 (human)
Putative in vivo kinases:
  • CAMK2A (mouse)
Regulatory protein:
  • MPRIP (mouse)
  • Raptor (mouse)
Treatment
  • A23187
  • EGTA
  • endothelin
  • insulin
  • ionomycin
  • LCMV_gp33-41_peptide
  • LPS
  • NAG-thiazoline
  • okadaic_acid
  • phorbol_ester
  • PTH(1-34)
  • PUGNAc
  • staurosporine
PEA-15 (human) kDIIRQPsEEEIIKL S116-p
PEA-15 iso2 (human) KDIIRQPSEEEIIKL S137
PEA-15 (mouse) KDIIRQPsEEEIIKL S116-p
PEA-15 (rat) KDIIRQPsEEEIIKL S116-p
PEA-15 (hamster) KDIIRQPsEEEIIKL S116-p
PEA-15 (cow) KDIIRQPsEEEIIKL S116-p